UK 00:04 Monday, 26 October 2026
Breaking news and expert analysis on fast-moving AIM and LSE listed shares
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Pot is clearly the new blockchain. Whatever. I do not pretend to understand this insanity. I am just too old. Anyhow the latest Primary Bid offer is from Highland Natural Resources (HNR) and if you want to play you can do so here.
Highlands is looking to raise a minimum of £1.27 million via a subscription for ordinary shares of 1 pence each and an offer for Ordinary Shares via PrimaryBid.com at a price of 8.5 pence.
We are told that “The funds raised will be used to establish an organic, vertically integrated cannabidiol ("CBD") operation in Colorado, USA, through a newly established and wholly-owned Highlands subsidiary, Zoetic Organics.
This initiative follows the completion of a recent trial, which saw hydrogen from Highlands' rare naturally occurring gas operation in Kansas, discovered during the summer of 2018, applied as a natural, organic fertiliser at a cannabis operation in Colorado. Encouragingly, the gas mixture increased plant size, height, root diameter and flower count by up to 30%, surpassing expectations.”
The shares closed at 10.2p-10.7p.
We get a few quid if any Primary Bid users registered via us take part (the deadline is 9PM tonight) but I am afraid that I cant take this terribly seriously. But maybe I am just an old fart who hasn’t smoked a joint for 31 years and will never do so again.
Some PB offers are nil brainers so we advise you all to sign up HERE to get notice of them. Whether you go on this particular trip is your call alone.
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
